Literature DB >> 22759795

Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling.

Richard Bridges1, Victoria Lutgen, Doug Lobner, David A Baker.   

Abstract

System x(c)(-) represents an intriguing target in attempts to understand the pathological states of the central nervous system. Also called a cystine-glutamate antiporter, system x(c)(-) typically functions by exchanging one molecule of extracellular cystine for one molecule of intracellular glutamate. Nonvesicular glutamate released during cystine-glutamate exchange activates extrasynaptic glutamate receptors in a manner that shapes synaptic activity and plasticity. These findings contribute to the intriguing possibility that extracellular glutamate is regulated by a complex network of release and reuptake mechanisms, many of which are unique to glutamate and rarely depicted in models of excitatory signaling. Because system x(c)(-) is often expressed on non-neuronal cells, the study of cystine-glutamate exchange may advance the emerging viewpoint that glia are active contributors to information processing in the brain. It is noteworthy that system x(c)(-) is at the interface between excitatory signaling and oxidative stress, because the uptake of cystine that results from cystine-glutamate exchange is critical in maintaining the levels of glutathione, a critical antioxidant. As a result of these dual functions, system x(c)(-) has been implicated in a wide array of central nervous system diseases ranging from addiction to neurodegenerative disorders to schizophrenia. In the current review, we briefly discuss the major cellular components that regulate glutamate homeostasis, including glutamate release by system x(c)(-). This is followed by an in-depth discussion of system x(c)(-) as it relates to glutamate release, cystine transport, and glutathione synthesis. Finally, the role of system x(c)(-) is surveyed across a number of psychiatric and neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22759795      PMCID: PMC3400835          DOI: 10.1124/pr.110.003889

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  372 in total

1.  Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange.

Authors:  Z C Ye; J D Rothstein; H Sontheimer
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

2.  Sustained neuronal activity generated by glial plasticity.

Authors:  Tiina M Pirttimaki; Stephen D Hall; H Rheinallt Parri
Journal:  J Neurosci       Date:  2011-05-25       Impact factor: 6.167

3.  Aminopeptidase N mediates the utilization of the GSH precursor CysGly by cultured neurons.

Authors:  R Dringen; J M Gutterer; C Gros; J Hirrlinger
Journal:  J Neurosci Res       Date:  2001-12-01       Impact factor: 4.164

4.  Block of glutamate transporters potentiates postsynaptic excitation.

Authors:  G Tong; C E Jahr
Journal:  Neuron       Date:  1994-11       Impact factor: 17.173

5.  Release by electrical stimulation of endogenous glutamate, gamma-aminobutyric acid, and other amino acids from slices of the rat medulla oblongata.

Authors:  M Kihara; Y Misu; T Kubo
Journal:  J Neurochem       Date:  1989-01       Impact factor: 5.372

6.  Quinone and oxyradical scavenging properties of N-acetylcysteine prevent dopamine mediated inhibition of Na+, K+-ATPase and mitochondrial electron transport chain activity in rat brain: implications in the neuroprotective therapy of Parkinson's disease.

Authors:  Maria B Bagh; Arpan K Maiti; Sirsendu Jana; Kalpita Banerjee; Arun Roy; Sasanka Chakrabarti
Journal:  Free Radic Res       Date:  2008-06

7.  Autocrine glutamate signaling promotes glioma cell invasion.

Authors:  Susan A Lyons; W Joon Chung; Amy K Weaver; Toyin Ogunrinu; Harald Sontheimer
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

8.  Oxidative stress impairs glutamate uptake in fibroblasts from patients with Alzheimer's disease.

Authors:  Barbara Begni; Laura Brighina; Elena Sirtori; Lorenzo Fumagalli; Simona Andreoni; Simone Beretta; Thierry Oster; Catherine Malaplate-Armand; Valeria Isella; Ildebrando Appollonio; Carlo Ferrarese
Journal:  Free Radic Biol Med       Date:  2004-09-15       Impact factor: 7.376

Review 9.  Cell signalling and the glutathione redox system.

Authors:  Giuseppe Filomeni; Giuseppe Rotilio; Maria Rosa Ciriolo
Journal:  Biochem Pharmacol       Date:  2002-09       Impact factor: 5.858

10.  Characterization of L-glutamic acid transport by glioma cells in culture: evidence for sodium-independent, chloride-dependent high affinity influx.

Authors:  R A Waniewski; D L Martin
Journal:  J Neurosci       Date:  1984-09       Impact factor: 6.167

View more
  77 in total

Review 1.  The good and bad news about glutamate in drug addiction.

Authors:  Sade Spencer; Michael Scofield; Peter W Kalivas
Journal:  J Psychopharmacol       Date:  2016-06-28       Impact factor: 4.153

2.  Localization of excitatory amino acid transporters EAAT1 and EAAT2 in human postmortem cortex: a light and electron microscopic study.

Authors:  R C Roberts; J K Roche; R E McCullumsmith
Journal:  Neuroscience       Date:  2014-07-24       Impact factor: 3.590

3.  Altered serine/threonine kinase activity in schizophrenia.

Authors:  Jennifer L McGuire; John H Hammond; Stefani D Yates; Dongquan Chen; Vahram Haroutunian; James H Meador-Woodruff; Robert E McCullumsmith
Journal:  Brain Res       Date:  2014-04-26       Impact factor: 3.252

4.  Synaptic glutamate spillover due to impaired glutamate uptake mediates heroin relapse.

Authors:  Hao-wei Shen; Michael D Scofield; Heather Boger; Megan Hensley; Peter W Kalivas
Journal:  J Neurosci       Date:  2014-04-16       Impact factor: 6.167

5.  Regulation of glutamate transporter 1 (GLT-1) gene expression by cocaine self-administration and withdrawal.

Authors:  Ronald Kim; Marian T Sepulveda-Orengo; Kati L Healey; Emily A Williams; Kathryn J Reissner
Journal:  Neuropharmacology       Date:  2017-09-14       Impact factor: 5.250

Review 6.  Redox-based therapeutics in neurodegenerative disease.

Authors:  G J McBean; M G López; F K Wallner
Journal:  Br J Pharmacol       Date:  2016-08-25       Impact factor: 8.739

7.  Glutamate transporter GLT-1 mediates N-acetylcysteine inhibition of cocaine reinstatement.

Authors:  Kathryn J Reissner; Cassandra D Gipson; Phuong K Tran; Lori A Knackstedt; Michael D Scofield; Peter W Kalivas
Journal:  Addict Biol       Date:  2014-02-25       Impact factor: 4.280

8.  Accumbens Mechanisms for Cued Sucrose Seeking.

Authors:  Ana-Clara Bobadilla; Constanza Garcia-Keller; Jasper A Heinsbroek; Michael D Scofield; Victoria Chareunsouk; Cara Monforton; Peter W Kalivas
Journal:  Neuropsychopharmacology       Date:  2017-07-20       Impact factor: 7.853

Review 9.  Glutamate and tumor-associated epilepsy: glial cell dysfunction in the peritumoral environment.

Authors:  Susan C Buckingham; Stefanie Robel
Journal:  Neurochem Int       Date:  2013-02-04       Impact factor: 3.921

10.  Microwave accelerated synthesis of isoxazole hydrazide inhibitors of the system xc- transporter: Initial homology model.

Authors:  Afnan A Matti; Joseph Mirzaei; John Rudolph; Stephen A Smith; Jayme L Newell; Sarjubhai A Patel; Michael R Braden; Richard J Bridges; Nicholas R Natale
Journal:  Bioorg Med Chem Lett       Date:  2013-08-27       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.